Terlipressin
Class
Antidiuretics
Subclass
Vasopressin analogs
Substance name
Terlipressin
Brand names
Terlivaz®
Common formulations
Powder for parenteral solution
Dosage and administration
Adults patients
Hepatorenal syndrome
Variceal hemorrhage • Off-label
Indications for use
Labeled indications
Adults
Off-label indications
Adults
Safety risks
Boxed warnings
Respiratory failure
Contraindications
Coronary, peripheral, or mesenteric ischemia
Hypoxia or worsening respiratory symptoms
Warnings and precautions
Ineligibility for liver transplant
Ischemic events
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Any modality
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: D
Breastfeeding
Use only if benefits outweigh potential risks.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource